Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 13 May 2026Incoming appointee
5 itemsScheduled Appointment Date26 June 2026 (including director candidates to be decided at the General Meeting of Shareholders on 26 June 2026)
Ito Masahiko (伊藤 雅彦)
Previous positionNot disclosed
New positionOutside directors
Sakamoto Takeshi (坂本 武志)
Previous positionDeputy General Manager, Logistics and Systems Planning Headquarters; General Manager, Logistics Planning Department
New positionExecutive Officer; General Manager, Logistics and Systems Planning Headquarters; General Manager, Logistics Planning Department; Deputy General Manager, Logistics Headquarters, 東邦薬品㈱
Tani Wataru (谷 亘)
Previous positionGeneral Manager, Human Resources Department, General Affairs and Human Resources Headquarters
New positionExecutive Officer; General Manager, Human Resources Department, General Affairs and Human Resources Headquarters
Kamo Kaoru (加茂 薫)
Previous positionSpecial Assignment General Manager, Office of the General Manager, Corporate Strategy Headquarters (responsible for the dispensing pharmacy business)
New positionExecutive Officer; Representative Director and Executive Vice President, ファーマクラスター㈱
Hashiba Tomoji (羽柴 知二)
Previous positionNot disclosed
New positionExecutive Officer; Deputy General Manager, Corporate Strategy Headquarters (responsible for the pharmaceutical wholesale business)
Departing officer
3 itemsDate of departure26 June 2026
Nakagomi Tsugio (中込 次雄)Next role stated
Former PositionSenior Executive Officer; General Manager, Logistics and Systems Planning Headquarters
New positionAdviser
Kobayashi Takashi (小林 孝)Next role stated
Former PositionExecutive Officer; General Manager, General Affairs and Human Resources Headquarters; General Manager, General Affairs Department; General Manager, Secretariat Office
New positionAdviser
Matsutani Takaaki (松谷 高顕)Next role stated
Former PositionAdviser
New positionRetirement
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Nakagomi Tsugio (中込 次雄) and Kobayashi Takashi (小林 孝) will not remain on the Board of Directors and are scheduled to become advisers. No information is provided regarding Matsutani Takaaki (松谷 高顕).
Directors after the change9Number
Shareholders’ meeting approvalDirector candidates will be decided at the General Meeting of Shareholders on 26 June 2026.
| Item | Details |
|---|---|
| Resolution date | 13 May 2026 |
| Scheduled Appointment Date | 26 June 2026 (including director candidates to be decided at the General Meeting of Shareholders on 26 June 2026) |
| Date of departure | 26 June 2026 |
| Name of appointee | Ito Masahiko (伊藤 雅彦), Sakamoto Takeshi (坂本 武志), Tani Wataru (谷 亘), Kamo Kaoru (加茂 薫), Hashiba Tomoji (羽柴 知二) |
| Appointee's new position | Outside directors, Executive Officer; General Manager, Logistics and Systems Planning Headquarters; General Manager, Logistics Planning Department; Deputy General Manager, Logistics Headquarters, 東邦薬品㈱, Executive Officer; General Manager, Human Resources Department, General Affairs and Human Resources Headquarters, Executive Officer; Representative Director and Executive Vice President, ファーマクラスター㈱, Executive Officer; Deputy General Manager, Corporate Strategy Headquarters (responsible for the pharmaceutical wholesale business) |
| Appointee's previous position | Not disclosed, Deputy General Manager, Logistics and Systems Planning Headquarters; General Manager, Logistics Planning Department, General Manager, Human Resources Department, General Affairs and Human Resources Headquarters, Special Assignment General Manager, Office of the General Manager, Corporate Strategy Headquarters (responsible for the dispensing pharmacy business), Not disclosed |
| Name of departing officer | Nakagomi Tsugio (中込 次雄), Kobayashi Takashi (小林 孝), Matsutani Takaaki (松谷 高顕) |
| Former position of departing officer | Senior Executive Officer; General Manager, Logistics and Systems Planning Headquarters, Executive Officer; General Manager, General Affairs and Human Resources Headquarters; General Manager, General Affairs Department; General Manager, Secretariat Office, Adviser |
| New position of departing officer | Adviser, Adviser, Retirement |
| Whether the incumbent will remain in office | Nakagomi Tsugio (中込 次雄) and Kobayashi Takashi (小林 孝) will not remain on the Board of Directors and are scheduled to become advisers. No information is provided regarding Matsutani Takaaki (松谷 高顕). |
| Number of directors after the change | 9, including 5 outside directors |
| Subject to Approval by the General Meeting of Shareholders | Director candidates will be decided at the General Meeting of Shareholders on 26 June 2026. |
Items this document does not state (9)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No specific reason for the changes is stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.